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Abstract
Caffeine and coffee are widely used among active individuals to enhance performance. The 
purpose of the current study was to compare the effects of acute coffee (COF) and caffeine 
anhydrous (CAF) intake on strength and sprint performance. Fifty-four resistance-trained males 
completed strength testing, consisting of one-rep max (1RM) and repetitions to fatigue (RTF) at 
80% of 1RM for leg press (LP) and bench press (BP). Participants then completed five, ten-second 
cycle ergometer sprints separated by one minute of rest. Peak power (PP) and total work (TW) 
were recorded for each sprint. At least 48 hours later, participants returned and ingested a beverage 
containing CAF (300 mg flat dose; yielding 3–5 mg/kg bodyweight), COF (8.9 g; 303 mg 
caffeine), or placebo (PLA; 3.8 g noncaloric flavoring) 30 minutes before testing. LP 1RM was 
improved more by COF than CAF (p=0.04), but not PLA (p=0.99). Significant interactions were 
not observed for BP 1RM, BP RTF, or LP RTF (p>0.05). There were no sprint × treatment 
interactions for PP or TW (p>0.05). 95% confidence intervals revealed a significant improvement 
in sprint 1 TW for CAF, but not COF or PLA. For PLA, significant reductions were observed in 
sprint 4 PP, sprint 2 TW, sprint 4 TW, and average TW; significant reductions were not observed 
with CAF or COF. Neither COF nor CAF improved strength outcomes more than PLA, while both 
groups attenuated sprint power reductions to a similar degree. Coffee and caffeine anhydrous may 
be considered suitable pre-exercise caffeine sources for high-intensity exercise.
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 Introduction
Caffeine is the most widely consumed psychoactive substance in the world, with estimates 
of average daily intakes as high as 4 mg/kg of bodyweight in US adults (Barone & Roberts, 
1996). Caffeine was first shown to improve exercise performance by Costill et al. (1978), 
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who demonstrated an increase in cycling time to exhaustion following coffee consumption. 
The primary ergogenic mechanism of caffeine is antagonism of adenosine receptors 
(Goldstein et al., 2010). Caffeine may also affect performance via both central and 
peripheral mechanisms by altering pain and effort perception (Doherty & Smith, 2005), 
calcium kinetics in the sarcoplasmic reticulum (Allen & Westerblad, 1995; Tallis, James, 
Cox, & Duncan, 2012; Weber & Herz, 1968), and sodium/potassium ATPase pump activity 
(M. Mohr, Nielsen, & Bangsbo, 2011), among other potential mechanisms (Goldstein et al., 
2010). Caffeine in doses of 3–6 mg/kg bodyweight has been consistently shown to enhance 
endurance performance (Goldstein et al., 2010), but findings have been equivocal in the 
context of strength and sprint performance. Evidence currently suggests that caffeine may 
improve sprint performance in trained subjects (Collomp, Ahmaidi, Chatard, Audran, & 
Prefaut, 1992; Juan Del Coso et al., 2012; Lara et al., 2014; Wiles, Coleman, Tegerdine, & 
Swaine, 2006; Woolf, Bidwell, & Carlson, 2008), but not in untrained subjects (Collomp, 
Ahmaidi, Audran, Chanal, & Prefaut, 1991; Crowe, Leicht, & Spinks, 2006; Greer, McLean, 
& Graham, 1998; Lorino, Lloyd, Crixell, & Walker, 2006). Collomp et al. (1992) 
investigated the effects of caffeine supplementation on sprint performance in both trained 
and untrained swimmers. By stratifying the sample based on training status, authors showed 
that sprint velocity was improved only in the highly-trained group of swimmers. This 
distinction may be related to anaerobic training adaptations, or reduced training variability in 
trained subjects.
Studies investigating caffeine’s effects on strength have reported mixed results. Although 
Woolf et al. (2008) reported an ergogenic effect of caffeine on chest press endurance, no 
improvement in leg press endurance was observed. Beck at al. (2006) documented an 
improvement in bench press one-rep max (1RM), but no improvement in bench press 
endurance, leg extension 1RM, or leg extension endurance. Subsequent research by Woolf et 
al. (2009) revealed no significant effect on bench press endurance, and Astorino et al. (2008) 
did not find any significant improvements in bench press or leg press 1RM or endurance 
after acute caffeine ingestion. More recent findings have shown caffeine intake to have 
beneficial effects on repetitions to fatigue (Duncan & Oxford, 2011; Duncan, Stanley, 
Parkhouse, Cook, & Smith, 2013; Hurley, Hatfield, & Riebe, 2013), subjective feelings of 
vigor and fatigue (Duncan & Oxford, 2011), and perceived exertion and muscle pain 
(Duncan et al., 2013). Conversely, Astorino et al. (2011) found statistically significant 
improvements in repetitions to fatigue for only one of four exercises tested; it was concluded 
that the ergogenic effect of acute caffeine intake was of little practical significance and that 
individual responses to supplementation were variable. It is possible that insufficient sample 
sizes, variation in individual responses, or differences in caffeine dosing and exercise 
protocols may partially explain inconsistent outcomes in research to date.
The first study reporting an ergogenic effect of caffeine used coffee as a caffeine source 
(Costill et al., 1978), but it was later suggested that coffee was less ergogenic than a 
caffeine-matched dose of caffeine anhydrous (Graham, Hibbert, & Sathasivam, 1998). 
Graham et al. (1998) compared the effects of coffee and caffeine anhydrous, and found that 
only caffeine anhydrous resulted in significant improvements in running time to exhaustion. 
The authors hypothesized that the differential responses to coffee and caffeine may be 
attributed to one or more of the numerous biologically active compounds found in coffee. 
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One such group of bioactive compounds, known as chlorogenic acids, are present in coffee 
in varying amounts (Crozier, Stalmach, Lean, & Crozier, 2012) and may antagonize 
caffeine’s effects on adenosine receptors (de Paulis et al., 2002). Contrary to this hypothesis, 
McLellan & Bell (2004) reported that the ergogenic effect of caffeine supplementation was 
not affected by coffee consumption 30 minutes prior. More recently, Hodgson et al. (2013) 
showed that energy-based target time trial performance was improved to a similar degree by 
caffeine-matched doses of coffee and caffeine anhydrous. While Graham et al. (1998) found 
no significant performance improvement following coffee ingestion, other studies have 
reported an ergogenic effect using similar doses of coffee before exercise (Costill et al., 
1978; Hodgson et al., 2013; Wiles, Bird, Hopkins, & Riley, 1992). Therefore, the purpose of 
the current study was to compare the effects of caffeine-matched doses of coffee and 
caffeine anhydrous on strength and repeated sprint performance. It was hypothesized that 
caffeine anhydrous ingestion would improve strength and sprint performance to a greater 
extent than coffee or placebo.
 Methods
 Experimental Design
The current study consisted of two laboratory visits, separated by at least 48 hours. Baseline 
testing included one-rep maximum (1RM) and repetitions to fatigue (RTF) for leg press (LP) 
and bench press (BP), and a repeated sprint protocol to determine peak power (PP) and total 
work output (TW). At least 48 hours after baseline testing, participants returned for a second 
visit. In a double-blind fashion, participants were randomly assigned, using random 
allocation software, into one of three equal groups consisting of either 300 mg caffeine 
anhydrous (CAF), a caffeine-matched dose of coffee (COF), or placebo (PLA). Thirty 
minutes after ingestion, exercise testing was repeated. All methodology was approved by the 
University’s Biomedical Institutional Review Board, and all participants signed an informed 
consent prior to participation.
 Subjects
Fifty-six male participants enrolled in the current study. Fifty-four participants (Mean ± SD; 
Age = 20.1 ± 2.1 yrs; Stature = 177.3 ± 5.6 cm; Body mass = 78.8 ± 8.8 kg) completed the 
study, as two participants dropped out after baseline testing for personal reasons. All 
participants were engaged in resistance training for at least 30 minutes a day, three days a 
week, for at least three months prior to the study, and weighed between 60–100 kg. 
Participants were excluded if they had supplemented with creatine or beta-alanine in the 
three months prior to the study. Participants were also excluded if dietary analysis or pre-
screening questionnaires revealed habitual caffeine intake of >800 mg per day, a history of 
sensitivity or adverse reactions to caffeine consumption, or regular consumption of any food 
or drug in a quantity that may significantly influence caffeine metabolism, such as grapefruit 
juice, cigarette smoke, and a number of pharmaceutical drugs. Participants were educated on 
various foods and beverages containing caffeine and asked to list their normal weekly intake 
of such products, which was used to calculate habitual caffeine intake for the sample (32.9 
± 59.6 mg/day; 0.42 mg/kg/day). Participants were encouraged to maintain normal diet and 
exercise habits throughout the duration of the study, but were asked to abstain from caffeine 
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intake for at least 48 hours prior to all exercise testing and abstain from vigorous exercise for 
at least 24 hours prior to testing. Participants completed a three-day diet log, which was 
analyzed using The Food Processor software (ESHA Research, Salem, OR, USA) to 
evaluate habitual dietary intakes. Exercise testing sessions took place at a similar time of day 
(± 2 hrs), and participants were instructed to replicate similar food intake before all lab 
visits. Descriptive characteristics and dietary intakes are listed by group in Table 1. No 
values were significantly different (p>0.05) between groups at baseline.
 One Rep Max (1RM) & Repetitions to Fatigue (RTF)
Participants completed a 1RM strength test, for LP followed by BP, using free weights and a 
spotter. To begin the warm up, each participant performed a set of 8–10 repetitions, with a 
weight that was approximately 50% of the predicted 1RM. Participants rested for 1–2 
minutes, after which a set of 4–6 repetitions was completed with a load of approximately 
80% of the predicted 1RM. After a 2-minute rest period, the weight was increased to an 
estimated 1RM load, and the participants attempted a single repetition with the weight. After 
the completion of each successful 1RM attempt, the weight was increased until failure was 
reached, with 2–3 minutes of rest between 1RM attempts. Once the 1RM was determined, 
participants were given a three minute rest period before the RTF test, in which participants 
lifted 80% of the 1RM load for as many continuous repetitions as possible in a single set, 
until a full repetition could no longer be completed with appropriate form. For subsequent 
post-testing, the load used for RTF tests remained constant (80% of baseline 1RM). For all 
testing sessions, 1RM and RTF testing for LP preceded BP. Reliability calculations from this 
laboratory indicate an intraclass correlation coefficient (ICC2,1) of 0.97 and 0.99 for LP and 
BP 1RM, respectively. The standard error of measurement (SEM) for LP and BP 1RM are 
7.4 kg and 1.9 kg, respectively.
 Repeated Sprint Protocol
Participants completed a repeated sprint test modified from the protocol described by Wiroth 
et al. (2001) ten minutes after the conclusion of strength testing. The test began with a self-
paced five minute warm up with a standardized load of 0.5 kg on a Monark friction-braked 
cycle ergometer (Ergomedic 894 E; Monark, Stockholm, Sweden). Following the warm up, 
participants completed a series of five maximal sprints lasting 10 seconds each, with a load 
of 95 g/kg of body mass. Participants were instructed to remain seated throughout the entire 
sprint and were verbally encouraged throughout the test. After each sprint, participants were 
given 60 seconds of passive recovery while seated on the cycle ergometer. For each sprint, 
PP and TW were evaluated using the default software (Monark ATS Software; Monark, 
Stockholm, Sweden). For this sprint protocol, reliability calculations from this laboratory 
indicate an ICC of 0.96 and SEM of 19.7 watts for average peak power.
 Supplementation
Participants were randomly assigned, according to a computer generated allocation 
sequence, to one of three treatments: 300 mg of caffeine anhydrous (CAF; 3–5 mg/kg body 
mass; Smart Powders, Graham, NC, USA) with noncaloric flavoring (Crystal Light; Kraft 
Foods, Northfield, IL, USA), 8.9 g of dehydrated coffee (COF; yields 303 mg caffeine [3–5 
mg/kg body mass]; Nescafé House Blend; Nestle, Vevey, Switzerland), or a placebo 
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beverage with noncaloric flavoring (3.8 g Crystal Light). Participants were required to weigh 
between 60–100 kg to ensure that the flat 300 mg caffeine dose provided a relative caffeine 
dose of 3–5 mg/kg body mass. Based on the average weight of each group, CAF received a 
relative caffeine dose of 3.85 mg/kg, and COF received 3.84 mg/kg. Blinding was completed 
by a member of the research staff that did not administer treatments. Supplements were 
mixed by research staff, with 350 mL of water, in opaque containers so neither participants 
nor investigators knew which treatment was being given. Supplements were consumed 30 
minutes prior to exercise testing. Due to the distinct coffee taste, this was considered a 
partially blinded study, although subjects were not aware if the coffee-flavored beverage was 
caffeinated or not. Previous research using a similar product verified a caffeine concentration 
of 3.4 g caffeine/100 g of instant coffee (Hodgson et al., 2013). As such, caffeine content 
was matched between CAF and COF (300 mg and 303 mg, respectively).
 Statistical Analysis
Data are expressed as mean ± standard deviation. A series of one-way ANOVAs were used 
to evaluate baseline differences between groups for dietary intakes and strength and sprint 
outcomes. For strength outcomes (1RM and RTF for LP and BP), change scores were 
calculated from baseline testing to post-testing. Four separate one-way ANOVAs were used 
to compare change scores between groups; in the event of a significant interaction, post hoc 
comparisons were analyzed using the Bonferroni method. When baseline values were 
significantly different between groups (LP RTF), change scores were analyzed using a one-
way ANCOVA, covaried for baseline values. In addition, 95% confidence intervals [mean 
± 1.96 × standard error of the mean (SEM)] were constructed for all strength outcomes. 
When the 95% confidence interval did not include zero, the change was considered 
significant (p≤0.05).
For each sprint, change scores from baseline to post-testing were calculated for both PP and 
TW. A series of two-way (3 × 5; treatment × sprint) mixed factorial ANOVAs were used to 
compare change scores between treatments for each sprint. The Bonferroni method was used 
to evaluate post hoc comparisons. Peak power and TW values were averaged between all 
five sprints to calculate average PP and TW for the entire sprint protocol, and change scores 
were calculated for these values. Measures of PP and TW were also evaluated using 95% 
confidence intervals. Analyses were performed using SPSS software (Version 20.0; IBM, 
Armonk, NY, USA), and 95% confidence intervals were calculated and plotted in Microsoft 
Excel (Version 2011, Microsoft Corporation; The Microsoft Network, LLC, Richmond, WA, 
USA). Statistical significance was set a priori at α≤0.05.
 Results
 Strength outcomes
There were no significant interaction effects for BP 1RM (p=0.78; Table 2) or BP RTF 
(p=0.47; Figure 1), indicating no difference in change scores between treatments. Only LP 
RTF was significantly different between groups at baseline (p=0.04). When covaried for 
baseline differences, change scores for LP RTF were not significantly different between 
groups (p=0.49; Figure 1). There was a significant interaction effect for LP 1RM (p=0.03); 
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post hoc comparisons revealed a significantly greater improvement in LP 1RM for COF 
compared to CAF (p=0.04), with no differences between COF and PLA (p=0.99) or CAF 
and PLA (p=0.10; Table 2).
Analysis of 95% confidence intervals of change scores revealed significant improvements 
for all groups in all strength measures (Figure 1; Table 2), with significantly greater 
improvements in LP 1RM for COF [CI: 10.7, 18.5 kg] in comparison to CAF [3.3, 10.6 kg].
 Sprint outcomes
For changes in PP, no sprint × treatment interaction was observed (p=0.17), with no main 
effects for sprint (p=0.24) or treatment (p=0.25). For changes in TW, no sprint × treatment 
interaction was observed (p=0.15). There was no main effect for treatment (p=0.16), but 
there was a significant main effect for sprint (p=0.02). Post hoc analyses showed a reduction 
in TW from Sprint 1 to Sprint 3 (p=0.03), with a nonsignificant TW reduction from Sprint 1 
to Sprint 4 (p=0.06).
Analysis of 95% confidence intervals revealed a significant increase in Sprint 1 TW for CAF 
[CI: 81.4, 623.9 joules (J)], but not for COF or PLA (Figure 2). Sprint 4 PP was significantly 
reduced in PLA [CI: −64.9, −2.5 watts (W)], but not in COF [−34.4, 36.6 W] or CAF 
[−42.8, 22.2 W]. Total work was significantly reduced in Sprint 2 [CI: −321.2, −66.1 J] and 
Sprint 4 [−403.1, −57.6 J] for PLA, but not for COF [−19.5, 439.3 J and −291.2, 118.3 J] or 
CAF [−415.8, 103.3 J and −300.9, 129.5 J]. Further, average TW was reduced in PLA [CI: 
−219.0, −40.2 J], but not in COF or CAF (Figure 2).
 Discussion
A number of studies have demonstrated that CAF supplementation improves endurance 
exercise performance (Goldstein et al., 2010). Far less research has investigated its effects on 
strength and sprint performance, and to our knowledge CAF and COF have not been directly 
compared in this context. Results of the current study revealed that neither CAF nor COF 
resulted in significantly greater 1RM or RTF outcomes than PLA for bench press or leg 
press. Analysis of 95% confidence intervals suggests an ergogenic effect of both CAF and 
COF during a repeated sprint protocol. Sprint 1 TW was significantly improved in CAF 
only. Further, PLA experienced reductions in sprint 4 PP, sprints 2 and 4 TW, and average 
TW, while these reductions were attenuated by both CAF and COF. The current results may 
have implications for anaerobic athletes seeking to improve repeated sprint performance 
with pre-exercise CAF or COF ingestion.
In the current study, BP 1RM, BP RTF, and LP RTF improved in all groups, with no 
significant differences between treatments. Despite the recruitment of resistance-trained 
participants, improvement in the PLA group may indicate that a learning or placebo effect 
led to improved performance. Interestingly, no such effect was observed for the cycling test, 
which was likely a more unfamiliar exercise test based on inclusion criteria. Coffee 
improved LP 1RM more than CAF, but not more than PLA. Previous CAF studies 
investigating similar strength measurements have reported equivocal results. Beck et al. 
(2006) demonstrated that pre-exercise CAF supplementation increased BP 1RM, but did not 
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affect BP endurance, leg extension 1RM, or leg extension endurance. Conversely, Woolf et 
al. (2008) found an improvement in chest press endurance, but not LP endurance. Other 
studies by Woolf et al. (2009) and Astorino et al. (2008) found no effect on BP endurance, 
and no effect BP or LP 1RM or endurance, respectively. Graham et al. (1998) previously 
indicated that CAF improved endurance performance more than a caffeine-matched dose of 
COF; more recent research has failed to support these findings (Hodgson et al., 2013). To 
our knowledge, the current study is the first to investigate this question in the context of 
strength and sprint performance, and results do not support the hypothesis that CAF is 
superior to COF for performance. Coffee improved LP 1RM more than CAF, but the 
underlying mechanism for this difference is not yet known. Previous research has indicated 
that individual responses to CAF can vary (Goldstein et al., 2010), and it is therefore 
possible that individuals in the CAF group reacted less favorably to caffeine than the COF 
group. Although large standard deviations suggest appreciable inter-individual differences in 
self-reported habitual daily caffeine intake, average intake was similar between CAF and 
COF groups (41.0 ± 64.5 mg vs. 33.3 ± 59.4 mg, respectively), and participants abstained 
from caffeinated products for a minimum of 48 hours prior to all testing sessions to 
eliminate short-term habituation. More research is needed to investigate this finding, but 
these results do not collectively demonstrate a consistent difference in strength outcomes 
between acute CAF, COF, or PLA ingestion.
In the current study, sprint 1 TW was significantly improved by CAF, but not by COF or 
PLA. Further, the PLA group experienced reductions in PP and TW during post-testing, 
while PP and TW were maintained with CAF or COF. These results indicate that both COF 
and CAF had an ergogenic effect on the repeated sprint test, with no clear difference 
between the two groups. These findings are consistent with previous research documenting 
improvements for both single (Woolf et al., 2008) and repeated sprint performance 
(Schneiker, Bishop, Dawson, & Hackett, 2006) in trained subjects with CAF use, and 
suggest that improvements are similar with COF. In the context of high-intensity sprints, the 
ergogenic effects of caffeine are most likely related to its effects on adenosine receptors 
(Goldstein et al., 2010) and pain/effort perception (Doherty & Smith, 2005). Participants in a 
previous study reported reduced leg pain during cycling to exhaustion at 60% of VO2 peak 
following caffeine ingestion (Cramer, 2008). While leg pain was not directly assessed in the 
current study, attenuation of pain or effort perception would likely be advantageous in the 
strenuous sprint protocol employed. Additionally, caffeine’s effects on cycling performance 
may relate to direct effects of caffeine on muscle. Electronically stimulated cycling time to 
exhaustion was improved by caffeine in a sample of paraplegic and tetraplegic participants 
(T. Mohr, Van Soeren, Graham, & Kjaer, 1998). Results indicated that this effect was not 
influenced by catecholamines, substrate utilization, or central factors, and was possibly 
attributable to peripheral effects on excitation-contraction coupling. Power reductions are 
not likely related to caffeine withdrawal, as habitual caffeine intake was low in the PLA 
group (24.2 ± 56.8 mg/day), and participants observed a standardized, 48-hour abstention 
from caffeinated products prior to baseline testing. While baseline testing and post-testing 
were separated by at least 48 hours, power reductions in the PLA group may relate to the 
strenuous nature of the testing session, or residual soreness or fatigue from pre-testing. 
These power reductions were attenuated by both CAF and COF, suggesting that CAF and 
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COF may be beneficial for athletes, who typically complete multiple strenuous training 
sessions within a given week.
Previous research has suggested that one or more of the bioactive compounds in COF, such 
as chlorogenic acids, may attenuate the ergogenic effect of caffeine (Goldstein et al., 2010; 
Graham et al., 1998). In agreement with more recent research (Hodgson et al., 2013; 
McLellan & Bell, 2004), results of the current study suggest that COF and CAF yield similar 
benefits for high-intensity exercise. While caffeine has previously been associated with 
negative health outcomes, recent research has suggested that habitual COF consumption 
may be beneficial after controlling for confounding variables such as smoking and heavy 
alcohol consumption (Freedman, Park, Abnet, Hollenbeck, & Sinha, 2012; Gonzalez de 
Mejia & Ramirez-Mares, 2014). Coffee contains numerous biologically active compounds, 
and authors have proposed that some of these compounds may counteract the negative health 
effects associated with caffeine intake (Gonzalez de Mejia & Ramirez-Mares, 2014). As 
such, COF may be considered a suitable source of caffeine prior to high-intensity exercise, 
with results of the current study suggesting a similar ergogenic effect when compared to 
CAF.
A limitation of the current study is the provision of a flat dose of caffeine (300 mg) rather 
than scaling the dosage to bodyweight. Previous studies have demonstrated that 3 or 6 mg/kg 
doses of caffeine improve endurance performance to a similar degree (Graham & Spriet, 
1995), and that a 3 mg/kg dose is sufficient to improve strength outcomes similar to those 
measured in the current study (Del Coso, Salinero, Gonzalez-Millan, Abian-Vicen, & Perez-
Gonzalez, 2012). Further, the ergogenic effects of caffeine supplementation do not generally 
follow a dose-response relationship (Graham & Spriet, 1995; Pasman, van Baak, 
Jeukendrup, & de Haan, 1995). Subjects in the current study reported low habitual caffeine 
intake (32.9 ± 59.6 mg/day), which may limit generalizability to heavy caffeine users. 
Although previous studies have suggested that changes in graded exercise performance 
(Dodd, Brooks, Powers, & Tulley, 1991), repeated sprint performance (Glaister et al., 2008), 
and stimulated muscle force (Tarnopolsky & Cupido, 2000) do not differ because caffeine-
habituated and caffeine-naïve subjects, more research on caffeine habituation is warranted. 
Many caffeine studies provide supplements one hour prior to exercise, whereas supplements 
in the current study were ingested 30 minutes prior to exercise. This time frame was selected 
because 90% of caffeine is cleared from the stomach within 20 minutes of ingestion, with 
peak values occurring as early as 30–45 minutes after ingestion (Gonzalez de Mejia & 
Ramirez-Mares, 2014), and because the exercise test protocol took roughly one hour to 
complete. Despite the recruitment of resistance-trained participants, it appeared that a 
learning effect or a placebo effect was observed for strength outcomes, but not for sprint 
outcomes. Finally, reductions in power output in the PLA group may suggest that CAF and 
COF attenuated fatigue throughout the series of exercise tests in post-testing. These power 
reductions could also indicate that participants were not fully recovered between pre- and 
post-testing sessions, which were separated by at least 48 hours. If so, attenuation of power 
decrements may reveal a valuable effect of CAF and COF for athletes completing multiple 
strenuous exercise bouts in the same week. While delayed onset muscle soreness (DOMS) 
generally peaks 24–72 hours after exercise (Cheung, Hume, & Maxwell, 2003), the average 
time between visits was similar in all groups and beyond the range for peak soreness (CAF = 
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6.1 days, COF = 5.3, PLA = 5.2). These values suggest that DOMS was not likely to 
confound between-group comparisons in the current study. Future research should seek to 
determine optimal dosing strategies for COF and CAF prior to high-intensity exercise.
 Conclusion
The current study demonstrated an ergogenic effect of caffeine-matched doses of CAF and 
COF on repeated sprint exercise, with no clear difference between treatments. Neither CAF 
nor COF improved strength outcomes compared to placebo. In trained males, caffeine dosed 
at 3–5 mg/kg may improve high-intensity sprint performance when ingested 30 minutes 
prior to exercise. Caffeine anhydrous does not appear to improve performance more than 
coffee. Given the health benefits of habitual coffee consumption (Gonzalez de Mejia & 
Ramirez-Mares, 2014), coffee appears to be a suitable source of caffeine to improve sprint 
performance, particularly when multiple strenuous bouts are completed in the same week.
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Figure 1. 
Effects of supplementation on leg press and bench press repetitions to fatigue. *Significant 
change from baseline, as determined by 95%CI; #significantly greater than CAF at baseline
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Figure 2. 
Changes in total work (TW; joules) after supplementation. *Significant change from 
baseline, as determined by 95%CI
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Table 1
Baseline characteristics and habitual dietary intakes by group for caffeine (CAF), coffee (COF), and placebo 
(PLA). Values are mean ± SD.
CAF (n=18) COF (n=18) PLA (n=18)
Age (yrs) 20.3 ± 2.3 20.3 ± 2.3 19.7 ± 1.6
Height (cm) 178.0 ± 4.8 176.4 ± 6.0 177.4 ± 6.2
Weight (kg) 77.9 ± 7.8 79.0 ± 10.7 79.4 ± 8.3
Calories (kcal) 2616.2 ± 745.9 2823.1 ± 615.8 2514.9 ± 549.5
CHO (g/day) 285.0 ± 94.0 308.0 ± 104.0 283.2 ± 98.1
FAT (g/day) 107.6 ± 43.6 113.7 ± 32.3 100.4 ± 29.5
PRO (g/day) 129.6 ± 32.6 142.8 ± 32.7 125.4 ± 35.0
CAF (mg/day) 41.0 ± 64.5 33.3 ± 59.4 24.2 ± 56.8
CHO = carbohydrate intake, PRO = protein intake, CAF = habitual caffeine intake
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Table 2
Effects of supplementation on leg press and bench press 1RM (kg)
LP 1RM (kg) BP 1RM (kg)
Treatment Pre Post Pre Post
CAF 283.5 ± 62.9 290.5 ± 64.1* 93.0 ± 18.5 94.7 ± 18.5*
COF 309.4 ± 86.3 324.0 ± 86.2*§ 95.5 ± 17.7 96.7 ± 18.1*
PLA 279.3 ± 69.1 292.8 ± 67.5* 86.9 ± 17.3 88.8 ± 17.1*
*Significant change from baseline, as determined by 95%CI
§Change score significantly greater than CAF
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